• Je něco špatně v tomto záznamu ?

Extrakce infikovaných stimulačních a defibrilačních elektrod
[Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram]

Grammes JA, et al.

. 2010 ; 4 (4) : 29-30.

Jazyk čeština Země Česko

Typ dokumentu srovnávací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc10028273

We describe the feasibility, safety, and clinical outcomes of percutaneous lead extraction in patients at a tertiary care center who had intracardiac vegetations identified by transesophageal echocardiogram. BACKGROUND: Infection in the presence of intracardiac devices is a problem of considerable morbidity and mortality. Patients with intracardiac vegetations are at high risk for complications related to extraction and protracted clinical courses. Historically, lead extraction in this cohort has been managed by surgical thoracotomy. METHODS: We analyzed percutaneous lead extractions performed from January 1991 to September 2007 in infected patients with echocardiographic evidence of intracardiac vegetations, followed by a descriptive and statistical analysis. RESULTS: A total of 984 patients underwent extraction of 1,838 leads; local or systemic infection occurred in 480 patients. One hundred patients had intracardiac vegetations identified by transesophageal echocardiogram, and all underwent percutaneous lead extraction (215 leads). Mean age was 67 years. Median extraction time was 3 min per lead; median implant duration was 34 months. During the index hospitalization, a new device was implanted in 54 patients at a median of 7 days after extraction. Post-operative 30-day mortality was 10%; no deaths were related directly to the extraction procedure. CONCLUSIONS: Patients with intracardiac vegetations identified on transesophageal echocardiogram can safely undergo complete device extraction using standard percutaneous lead extraction techniques. Permanent devices can safely be reimplanted provided blood cultures remain sterile. The presence of intracardiac vegetations identifies a subset of patients at increased risk for complications and early mortality from systemic infection despite device extraction and appropriate antimicrobial therapy. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram

Recenze v:

Komentář [k článku Extrakce infikovaných stimulačních a defibrilačních elektrod].

000      
00000naa 2200000 a 4500
001      
bmc10028273
003      
CZ-PrNML
005      
20111210192729.0
008      
101025s2010 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Grammes, Jon A.
245    10
$a Extrakce infikovaných stimulačních a defibrilačních elektrod / $c Grammes JA, et al.
246    11
$a Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram
314    __
$a Division of Cardiovascular Diseases, Drexel University College of Medicine, Philadelphia, Pennsylvania
520    9_
$a We describe the feasibility, safety, and clinical outcomes of percutaneous lead extraction in patients at a tertiary care center who had intracardiac vegetations identified by transesophageal echocardiogram. BACKGROUND: Infection in the presence of intracardiac devices is a problem of considerable morbidity and mortality. Patients with intracardiac vegetations are at high risk for complications related to extraction and protracted clinical courses. Historically, lead extraction in this cohort has been managed by surgical thoracotomy. METHODS: We analyzed percutaneous lead extractions performed from January 1991 to September 2007 in infected patients with echocardiographic evidence of intracardiac vegetations, followed by a descriptive and statistical analysis. RESULTS: A total of 984 patients underwent extraction of 1,838 leads; local or systemic infection occurred in 480 patients. One hundred patients had intracardiac vegetations identified by transesophageal echocardiogram, and all underwent percutaneous lead extraction (215 leads). Mean age was 67 years. Median extraction time was 3 min per lead; median implant duration was 34 months. During the index hospitalization, a new device was implanted in 54 patients at a median of 7 days after extraction. Post-operative 30-day mortality was 10%; no deaths were related directly to the extraction procedure. CONCLUSIONS: Patients with intracardiac vegetations identified on transesophageal echocardiogram can safely undergo complete device extraction using standard percutaneous lead extraction techniques. Permanent devices can safely be reimplanted provided blood cultures remain sterile. The presence of intracardiac vegetations identifies a subset of patients at increased risk for complications and early mortality from systemic infection despite device extraction and appropriate antimicrobial therapy. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a katetrizace $x metody $7 D002404
650    _2
$a defibrilátory implantabilní $x škodlivé účinky $7 D017147
650    _2
$a odstranění implantátu $x metody $7 D020878
650    _2
$a echokardiografie transezofageální $7 D017548
650    _2
$a elektrokardiografie $7 D004562
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a kardiostimulátor $x škodlivé účinky $7 D010138
650    _2
$a infekce spojené s protézou $x diagnóza $x epidemiologie $x chirurgie $7 D016459
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
650    _2
$a tachykardie $x terapie $7 D013610
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Pennsylvania $x epidemiologie $7 D010414
655    _2
$a srovnávací studie $7 D003160
773    0_
$w MED00012706 $t Clinical cardiology alert $g Roč. 4, č. 4 (2010), s. 29-30 $x 1213-2586
787    18
$w bmc10028274 $i Recenze v: $t Komentář [k článku Extrakce infikovaných stimulačních a defibrilačních elektrod]
910    __
$a ABA008 $b B 2242 $c 407 a $y 7
990    __
$a 20101013125906 $b ABA008
991    __
$a 20110131102239 $b ABA008
999    __
$a ok $b bmc $g 803387 $s 668160
BAS    __
$a 3
BMC    __
$a 2010 $b 4 $c 4 $d 29-30 $m Clinical Cardiology Alert $x MED00012706
LZP    __
$a 2010-29/mkme

Najít záznam